These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Immunosuppressive therapy chronic polyarthritis]. Thumb N Wien Z Inn Med; 1972 Dec; ():Suppl:1-52. PubMed ID: 4574028 [No Abstract] [Full Text] [Related]
7. The clinical use of immunosuppressive drugs. Forbes IJ Med J Aust; 1973 Apr; 1(15):749-52. PubMed ID: 4707372 [No Abstract] [Full Text] [Related]
8. British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011. Meggitt SJ; Anstey AV; Mohd Mustapa MF; Reynolds NJ; Wakelin S Br J Dermatol; 2011 Oct; 165(4):711-34. PubMed ID: 21950502 [No Abstract] [Full Text] [Related]
9. [Current status of immunosuppressive therapy in non-neoplastic disorders]. Grob PJ Schweiz Med Wochenschr; 1970 Apr; 100(16):703-7. PubMed ID: 4946733 [No Abstract] [Full Text] [Related]
10. [Chlorambucil within the framework of the treatment of rheumatoid polyarthritis with immuno-depressive agents]. Verhaeghe A; Delcambre B; Lesage R; Derreumaux LL; Cardon A Lille Med; 1970; 15(6):893-900. PubMed ID: 5454725 [No Abstract] [Full Text] [Related]
12. [The use of immunosuppressive drugs in the treatment of rheumatoid arthritis]. Pascual Gómez E Med Clin (Barc); 1983 Oct; 81(12):540-4. PubMed ID: 6656371 [No Abstract] [Full Text] [Related]
13. Cyclophosphamide in the treatment of the nephrotic syndrome in childhood. Spitzer A Pediatrics; 1972 Sep; 50(3):358-60. PubMed ID: 5056408 [No Abstract] [Full Text] [Related]
14. Immunological defence mechanisms and immuno-suppressive therapy in rheumatoid arthritis. Denman AM Adv Clin Pharmacol; 1974; 6():105-13. PubMed ID: 4619740 [No Abstract] [Full Text] [Related]
15. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"]. Krüger K MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140 [No Abstract] [Full Text] [Related]
16. [Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis]. Baixauli Rubio A; Rodríguez Górriz E; Campos Fernández C; Calvo Catalá J; García Vicente S An Med Interna; 2003 May; 20(5):276-7. PubMed ID: 12831311 [No Abstract] [Full Text] [Related]
17. [Therapy using cytostatics. Desired and undesired effects]. Hartwich G Fortschr Med; 1973 Nov; 91(31):1218-22. PubMed ID: 4751347 [No Abstract] [Full Text] [Related]
18. [Adverse effects of immunosuppressive therapy]. Kölle G Dtsch Med Wochenschr; 1969 Dec; 94(49):2568. PubMed ID: 5358566 [No Abstract] [Full Text] [Related]
19. [Side effects of immunosuppressants used in rheumatology]. de Seze S; Kahn MF Therapie; 1976; 31(3):377-84. PubMed ID: 1087053 [No Abstract] [Full Text] [Related]
20. [Risks of long-term therapy with immunosuppressive agents (proceedings)]. Thumb N Acta Med Austriaca Suppl; 1976; 3():203. PubMed ID: 1072574 [No Abstract] [Full Text] [Related] [Next] [New Search]